CBD Co. Says Buyer Class Action Should Wait For FDA Rule
By Dave Simpson ( March 12, 2020, 7:26 PM EDT) -- A Florida maker of CBD supplements asked a Massachusetts federal court Wednesday to toss or pause a proposed class action over the potency of its products because the U.S. Food and Drug Administration is mulling rules for how the products are labeled and marketed....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.